Ambulatory Surgery Centres Market: Global Industry Analysis and Forecast (2023-2029)

Ambulatory Surgery Centres Market is anticipated to reach US$ 27.38 Bn. by 2029 from US$ 12.46 Bn. in 2022 at a CAGR of 11.9% during a forecast period.

ASCs are modern healthcare facilities in which procedures are conducted in fully equipped operating rooms by highly qualified physicians and nurses. These facilities typically serve patients who do not need to be admitted to hospitals for treatment. The therapy can be conducted outside of the hospital, and the patient can be discharged immediately once the medical operation is completed. Ambulatory surgery facilities are a good option for persons who cannot afford to pay large medical expenditures.To know about the Research Methodology:- Request Free Sample Report
Ambulatory Surgery Centres Market Dynamics:
The global ambulatory surgical centers market is being driven largely by rising Medicare expenditure on ambulatory surgery centers and a greater emphasis on cost control in healthcare. Increasing the types of treatments offered at a single ASC provides a broader variety of reimbursement opportunities. In the report, the revenue impact of the covid-19 pandemic on the sales revenue of market leaders, market followers, and disruptors was examined, and this is represented in our analysis.

ASCs are largely focused on an increasing number of facilities and procedures done. An increase in the frequency of accidents has increased demand for procedures, propelling the overall market growth. The expansion of ambulatory surgical centres is expected to outstrip that of the hospital outpatient surgical sector. Furthermore, market consolidation and technical developments have enabled ASCs to serve increasingly complex situations such as complete hip replacement, plasma treatment, major spine surgery, and platelet transfusion.

Various healthcare organizations, such as Health Maintenance Organizations (HMOs), healthcare systems, and major group practices, are creating several specialist facilities inside the grounds of their primary healthcare facility to gain a competitive worldwide market share. This allows the facility to expand more quickly and earn a bigger market share. As a result, the industry is extremely competitive, and market participants are finding it difficult to profit.

The global ambulatory surgical centers market is seeing a decline in the number of free-standing ambulatory surgical centers, as more centers are being built within larger facilities that offer a wider range of ambulatory care services to achieve economies of scale and gain a competitive edge.
Ambulatory Surgery Centres Market Segmentation Analysis
By Specialty Type, The multispecialty segment is expected to increase at a CAGR of around 5% during the forecast period, and it had the largest market share in 2022. By 2029, the rising prevalence of chronic illnesses would propel the multispecialty segment forward. The market for ambulatory surgical centres in the multispecialty category will be driven by physicians' & patients' preference for less invasive procedures, as well as increased Medicare expenditure on ASCs for a variety of surgeries like hysterectomy and lumbar spine surgery, to mention a few.

By Ownership, The rising occurrence of diseases such as ophthalmic problems, diabetes, and other minor ailments that require expert care would increase the demand for specific treatment processes and specialized care requirements, which is expected to benefit single-specialty ASCs. Single-specialty centres are capable of giving disease-specific therapies that effectively enhance the patient's health.
Physician-owned ASCs' reduced surgical procedure costs relative to other ASCs, minimal overheads, favorable reimbursements, and other related factors are expected to drive revenue growth in the Physicians Only category. The need for the therapy of many chronic ailments and diseases is expected to drive the growth of the hospitals and physicians segment.

Hospital-physician collaborations are expected to help to reduce the limited treatment patterns that are designed to handle a specific disease, hence encouraging segment growth. Furthermore, rising rates of fungal, viral, and bacterial infections have resulted in an upward shift in demand for improved disease treatment, propelling the total ambulatory surgery centres market growth.

By Service, Due to an increase in demand for dental care among the newborn and geriatric populations, the dental segment is expected to grow at a high rate. The senior population in the United States is expected to quadruple by 2029, boosting the market growth. The growth of the ambulatory surgical centres market will be aided by the fact that the baby population has the highest prevalence of cavities and other dental issues.

The segment is expected to rise due to increased usage of cell phones and continued exposure to laptops and PCs at work. Furthermore, the emergence of minimally invasive surgical techniques for treating ocular problems would promote the market expansion of ambulatory surgical centres. The rising frequency of eye illnesses such as night blindness, cataracts, and other conditions has increased demand for procedures, boosting the ophthalmology segment's growth.
Ambulatory Surgery Centres Market Regional Insights
North America dominated the worldwide market in 2022 with a share of more than 39% and is expected to retain its dominance throughout the forecast period. The region's well-developed healthcare facilities, as well as the presence of many large-scale biotechnologies and medical device businesses, such as Arthrex, Inc.; Zimmer Biomet; Medtronic; Novartis AG; and Stryker, are boosting the market growth.

The increase in per capita income in the United States has greatly aided the population's ability to contribute to the healthcare industry. Furthermore, technical progress accelerates the market growth. The United States is expected to dominate the North American ambulatory surgical centres market due to a rise in the prevalence of old age disorders, which would necessitate more treatment at a lower cost.

Skin and eye disorders have increased the need for procedures in India's ambulatory surgical centres market as a result of increased exposure to polluted air. Because of the rising need for operations, India is expected to have a considerable market position in the APAC ambulatory surgical centres market. Furthermore, technological advancements are expected to help in the provision of higher-quality medical devices to hospitals, resulting in market growth.
Report Objectives:
Landscape analysis of the Ambulatory Surgery Centres Market

competitive benchmarking

Past and current status of the industry with the forecasted market size and trends

Evaluation of potential key players that include market leaders, followers, and new entrants

Technology trends

Potential impact of micro-economic factors of the market

External and Internal factors affecting market have been analysed

The report also helps in understanding the Ambulatory Surgery Centres Market dynamics, structure by analysing the market segments and project the Ambulatory Surgery Centres Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Ambulatory Surgery Centres Market make the report investor’s guide.
Ambulatory Surgery Centres Market Scope: Inquire before buying



Ambulatory Surgery Centres Market


Report Coverage
Details


Base Year:
2022
Forecast Period:
2023-2029


Historical Data:
2018 to 2022
Market Size in 2022:
US $ 12.46 Bn.


Forecast Period 2023 to 2029 CAGR:
11.9%
Market Size in 2029:
US $ 27.38 Bn.


 Segments Covered:
by Ownership
Physician Owned
Hospital Owned
Corporation Owned
Physician & Hospital
Physician & Corporation
Hospital & Corporation


by Specialty Type
Single Specialty
Multispecialty


by Service
Dental
Urology
Otolaryngology
Endoscopy
Obstetrics/Gynecology
Ophthalmology
Orthopedic
Cardiovascular
Neurology
Cosmetic Surgery
Podiatry



Ambulatory Surgery Centres Market by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Ambulatory Surgery Centres Market Key Players are:
1. Stryker Corp
2. Medtronic PLC
3. Zimmer Biomet
4. Novartis International AG
5. 21st Century Medicine
6. Biolife Solutions
7. Teva Pharmaceutical
8. Veloxis Pharmaceuticals
9. GlaxoSmithKline Plc
10.AbbVie Inc
11.Pfizer Inc
12.Astellas Pharma Inc
13.Gilead Sciences Inc
14.Quark Pharmaceuticals Inc
15.Takeda Pharmaceutical Company Ltd
16.Sanofi
17.Boehringer Ingelheim
Frequently Asked Questions
1. What is the projected market size & growth rate of Ambulatory Surgery Centres Market?
Ans- Ambulatory Surgery Centres Market was valued at USD 12.46 billion in 2022 and is projected to reach USD 27.38 billion by 2029, growing at a CAGR of 11.9% during the forecast period.

2. What are the key driving factors for the growth of Ambulatory Surgery Centres Market?
Ans- The global ambulatory surgical centers market is being driven largely by rising Medicare expenditure on ambulatory surgery centers and a greater emphasis on cost control in healthcare.

3. Which Region accounted for the largest Ambulatory Surgery Centres Market share?
Ans- North America dominated the worldwide market in 2022 with a share of more than 39% and is expected to retain its dominance throughout the forecast period.

4. What makes North America a Lucrative Market for Ambulatory Surgery Centres Market?
Ans- The region's well-developed healthcare facilities, as well as the presence of many large-scale biotechnologies and medical device businesses, are driving the market growth.c

5. What are the top players operating in Ambulatory Surgery Centres Market?
Ans- Stryker Corp, Medtronic PLC, Zimmer Biomet, Novartis International AG, 21st Century Medicine, Biolife Solutions, and Teva Pharmaceutical.